Recipients of the 2022 ICR Early Career Investigator in Cancer Award

The Early Career Investigator in Cancer Award recognizes the excellence of research conducted in Canada and is presented to the new investigators who submitted the highest-ranking grants from the Fall competition of the Project Scheme.

The Institute of Cancer Research congratulates the 2022 Early Career Investigator in Cancer Award recipients:

Dr. Houda Bahig is a clinician scientist and radiation oncologist at the Centre Hospitalier de l’Université de Montréal, who specializes in the treatment of head and neck cancers and thoracic malignancies. Her research is centered around the development of evidence-based "personalized radiotherapy" approaches by incorporating novel imaging methods.

Dr. Tanveer Sharif is a pharmacist turned researcher, who joined the University of Manitoba as a Principal Investigator to lead a new Tumour Suppressor Biology and Metabolism program in the department of Pathology. His research is focused on identifying and characterizing new metabolism-based precision medicine therapeutic strategies for treating aggressive brain tumors.

Dr. Geneviève Deblois is a Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) and an Assistant Professor in the Faculty of Pharmacy at the University of Montreal. She leads a research group that aims to better understand the role of epigenetic and metabolic rewiring in tumor progression and in the development of drug resistance.

Dr. April A. Rose is a clinician scientist and Assistant Professor within the Department of Oncology at McGill University and a Principal Investigator at the Lady Davis Institute for Medical Research. Dr. Rose has clinical interests in melanoma and genitourinary cancers. Her research interests are in molecular and translational oncology as well as in the development of novel immunogenomic therapies for treatment resistant cancers.

Date modified: